Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort

PURPOSES: Brain metastases (BM) are a frequent complication in small cell lung cancer (SCLC), resulting in a reduced survival prognosis. Precise prognostic assessment is an important foundation for treatment decisions and clinical trial planning. METHODS: Patients with newly diagnosed SCLC BM were i...

Descripción completa

Detalles Bibliográficos
Autores principales: Steindl, Ariane, Schlieter, Franziska, Klikovits, Thomas, Leber, Elena, Gatterbauer, Brigitte, Frischer, Josa M., Dieckmann, Karin, Widhalm, Georg, Zöchbauer-Müller, Sabine, Hoda, Mir Ali Reza, Preusser, Matthias, Berghoff, Anna S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775039/
https://www.ncbi.nlm.nih.gov/pubmed/31456143
http://dx.doi.org/10.1007/s11060-019-03269-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775039/
https://www.ncbi.nlm.nih.gov/pubmed/31456143
http://dx.doi.org/10.1007/s11060-019-03269-x

Ejemplares similares